Cited by

• Review of targeted therapy in chronic lymphocytic leukemia: what a radiologist needs to know about CT interpretation.

  Gosangi B, Davids M, Somarouthu B, Alessandrino F, Giardino A, Ramaiya N, Krajewski K. Gosangi B, et al. Cancer Imaging. 2018 Apr 18;18(1):13. doi: 10.1186/s40644-018-0146-8. Cancer Imaging. 2018. PMID: 29669600 Free PMC article. Review.
• [Chronic lymphocytic leukemia: current standards and novel approaches].

  Tausch E, Stilgenbauer S. Tausch E, et al. Internist (Berl). 2014 Dec;55(12):1400, 1402-4, 1406-9. doi: 10.1007/s00108-014-3556-0. Internist (Berl). 2014. PMID: 25392275 German.
• Exploration of Novel Inhibitors for Bruton's Tyrosine Kinase by 3D QSAR Modeling and Molecular Dynamics Simulation.

  Bavi R, Kumar R, Choi L, Woo Lee K. Bavi R, et al. PLoS One. 2016 Jan 19;11(1):e0147190. doi: 10.1371/journal.pone.0147190. eCollection 2016. PLoS One. 2016. PMID: 26784025 Free PMC article.
• Targeting the B-cell receptor signaling pathway in B lymphoid malignancies.

  Buchner M, Müschen M. Buchner M, et al. Curr Opin Hematol. 2014 Jul;21(4):341-9. doi: 10.1097/MOH.0000000000000048. Curr Opin Hematol. 2014. PMID: 24811161 Free PMC article. Review.
• Ibrutinib: from bench side to clinical implications.

  Grisafi D, Maestro A, Grumi C, Piazzoni L, Tirone G, Fiore W, Tessari R, Gianardi V, Gatti M, Tasca F, Generali D, Ravelli A, Lanza F, Scaglione F. Grisafi D, et al. Med Oncol. 2015 Sep;32(9):225. doi: 10.1007/s12032-015-0669-9. Epub 2015 Jul 30. Med Oncol. 2015. PMID: 26223732 Review.